Open call: Merck Foundation Diabetes and Hypertension Song Awards 2024
Submissions are currently ongoing for Merck Foundation’s Diabetes and Hypertension Song Awards 2024.
Merck Foundation is the philanthropic arm of Merck KGaA Germany, and the contest is running in partnership with the First Ladies of Africa. The initiative seeks to raise awareness about the prevention and early detection of diabetes and hypertension by inviting musicians to showcase their work and deliver messages promoting a healthy lifestyle.
Who Can Apply
The contest is open to both established and undiscovered African singers and musical artists.
How to Apply
- Applicants should share their song file along with the lyrics via email to submit@merck-foundation.com.
- The subject line of the email must include: Merck Foundation SONG AWARDS “Diabetes and Hypertension” 2024.
- Applicants are required to specify their name, country, and contact details in the email.
The deadline for application is 30 October.
“I strongly believe that music has the power to touch the hearts and souls of people, bind communities, and bring about a cultural shift in society,” Merck Foundation CEO Rasha Kelej said. “Music and art can influence to make the problem felt, which further stimulates emotions and leads to engagement and action.
“Music is a strong tool that is very critical in raising awareness on important critical issues prevalent in African countries, in an entertaining and innovative way. Therefore, together with my dear sisters, African First Ladies, we invite creative entries from our African talents to create songs about diabetes & hypertension awareness and promoting healthy lifestyle.”
Merck Foundation has also released ‘No More Diabetes, Sugar-Free’ song in three languages, sung by Cwesi from Ghana, Portuguese version ‘Chega de Diabete’ sung by Hot Blaze of Mozambique, French version ‘Dites non au Diabète’ sung by Laura Beg from Mauritius. The songs are available for streaming here.
For more information, visit the official Merck Foundation website.
Comments
Log in or register to post comments